CAS Number: 84696-11-7
Plant that is widely used even during pregnancy and breastfeeding. Because a lack of toxicity with an appropriate dose and moderate consumption it should be compatible with breastfeeding. The roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids among others. Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications are: common cold, bronchitis, skin lesions.Roots and aerial summits are used. It contains polysaccharides, essential oil, flavonoids, pyrrolizidine alkaloids ... Unproven effects: immune stimulant, wound healing, anti-inflammatory. Indications according to Commission E of German Ministry of Health: common cold, bronchitis, skin lesions. Contrary to the European Scientific Cooperative on Phytotherapy (ESCOP), the European Medication Agency does not recommend usage in younger than 12 years (allergy risk). Avoid using for longer than 8 weeks (risk for leukopenia)
Used in the treatment of promyelocitic leukemia in adults.
Cinchona alkaloid used in the prophylaxis and treatment of malaria (Pérez 2009). Administered orally or intravenously. It is excreted in breast milk in clinically insignificant amounts (Mathew 2004, Phillips 1986, Terwilliger 1934), much lower than the dose used in newborns and infants (Fulton 1992).No problems have been observed in infants whose mothers were taking it (FDA 2008, Terwilliger 1934). Its use is authorized in infants and children.Avoid in cases of glucose-6-phosphate dehydrogenase deficiency (Mathew 2004, WHO/UNICEF 2002, Fulton 1992). American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001). WHO list of essential medicines: compatible with breastfeeding (WHO / UNICEF, 2002).
CAS Number: 84775-56-4
A parasitic fungus from the ear of some cereals, particularly rye, which since ancient times has caused epidemics of a serious disease, ergotism (Florea 2017, Belser 2013, Lee 2009). It has a complex composition, highlighting the ergoline alkaloids: lysergic acid amides such as ergometrine and ergopeptines such as ergotamine and ergotoxine (Florea 2017, Hulvová 2013) that act on adrenergic, dopaminergic and serotonergic receptors. Since the last update, we have not found published data on its excretion in breast milk. Ergot alkaloids have oxytocic, vasoconstrictive and lactation-inhibiting effects by inhibiting prolactin, among many others (Florea 2017, Hulvová 2013, Lee 2010, Lee 2009). Indications from the German Ministry of Health’s Commission E: none. Due to its serious adverse reactions and toxicity, natural alkaloids are not used in therapy, and there are recommendations for their withdrawal from sale (EMA 2014). At present, semisynthetic derivatives such as methylergometrine, dihydroergotamine, dihydroergocristine, bromocriptine and lisuride are used, among others. See below the information of these related products:
CAS Number: 84696-11-7; 90028-20
Echinacea species (Echinacea angustifolia, Echinacea purpurea, Echinacea pallida) contain high molecular weight polysaccharides (e.g., heteroxylan, arabinogalactan) and lower molecular weight compounds (e.g., alkylamides, caffeoyl conjugates such as cichoric acid and echinacosides), but no single chemical is known to be responsible for echinacea's biological activity. Some products have been standardized based on echinacoside, and others on cichoric acid. Echinacea has no specific uses during breastfeeding, but is commonly used orally to treat or prevent upper respiratory infections. It is also used topically to treat skin infections. Excretion of some of the purportedly active alkamides was found in breastmilk in one mother. No data exist on the safety and efficacy of echinacea in nursing mothers or infants. In general, echinacea is well tolerated with gastrointestinal upset, diarrhea and constipation, skin rash and rarely allergic reactions reported. It may also alter the metabolism of some dugs metabolized by the P450 enzyme system. Some sources indicate that echinacea is safe in recommended doses, while others recommend avoiding it during breastfeeding because of the lack of published safety data. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 1327-53-3
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk. Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.
CAS Number: 130-95-0
Because of the low levels of quinine in breastmilk, amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants. The dosage in milk is far below those required to treat an infant for malaria. However, quinine should not be used in mothers with an infant who is glucose-6-phosphate dehydrogenase (G6PD) deficient. Even the relatively small amounts of quinine in tonic water ingested by the mother have caused hemolysis in G6PD-deficient infants.
Wild indigo is an herb. The root is used to make medicine.Wild indigo is used for infections such as diphtheria, influenza (flu), swine flu, the common cold and other upper respiratory tract infections, lymph node infections, scarlet fever, malaria, and typhoid. It is also used for sore tonsils (tonsillitis), sore throat, swelling of the mouth and throat, fever, boils, and Crohns disease. Some people apply wild indigo directly to the skin for ulcers, sore and painful nipples, as a douche for vaginal discharge, and for cleaning open and swollen wounds. Wild indigo is UNSAFE when taken by mouth or applied to the skin, long-term or in large doses. Large doses can cause vomiting, diarrhea, other intestinal problems, and spasms.
While breastfeeding wild indigo is likely not safe when taken by mouth or applied to the skin. Avoid use.
Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Septaforce is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.
Homeopathic medicines are usually safe in breastfeeding and if Septaforce has been recommended by doctor then there should be no concern about its usage in breastfeeding.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week